Choriocapillaris Changes Imaged by OCT Angiography After Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

被引:23
|
作者
Fujita, Kyoko [1 ]
Kawamura, Akiyuki [2 ]
Yuzawa, Mitsuko [2 ]
机构
[1] Kansai Med Univ, 2-5-1 Shinmachi, Hirakata, Osaka 5731010, Japan
[2] Nihon Univ, Chiyoda Ku, Tokyo, Japan
来源
OPHTHALMIC SURGERY LASERS & IMAGING RETINA | 2017年 / 48卷 / 04期
关键词
INDOCYANINE GREEN ANGIOGRAPHY; VERTEPORFIN; LEVEL;
D O I
10.3928/23258160-20170329-04
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
BACKGROUND AND OBJECTIVE: To evaluate the choriocapillaris using optical coherence tomographic angiography (OCTA) after half-dose verteporfin photodynamic therapy (hd-PDT) for chronic central serous chorioretinopathy (CSC). PATIENTS AND METHODS: We studied six eyes (six patients) with chronic CSC treated by hd-PDT. OCTA was performed before, 1 week after, and 1 month after hd-PDT. The area of flow abnormality at the choriocapillaris level within the PDT spot after hd-PDT was compared with that before hd-PDT. RESULTS: Serous retinal detachment was diminished in all eyes, with three achieving complete resolution at 1 month. On OCTA, all eyes showed irregular choriocapillaris flow before hd-PDT. The areas of abnormal flow shrank progressively at 1 month after hd-PDT. CONCLUSION: On OCTA, choriocapillaris flow tended to recover at 1 month after hd-PDT. OCTA may be clinically useful for evaluating choriocapillaris and the therapeutic effects of hd-PDT for chronic CSC.
引用
收藏
页码:302 / 310
页数:9
相关论文
共 50 条
  • [41] Safety and efficacy of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Feenstra, Helena Margaret Anthonia
    Diederen, Roselie M. H.
    Lamme, Martine J. C. M.
    Fauser, Sascha
    Downes, Susan M.
    Schlingemann, Reinier O.
    Hoyng, Carel C. B.
    van Dijk, Elon H. C.
    Boon, Camiel J. F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [42] Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy
    van Rijssen, Thomas J.
    van Dijk, Elon H. C.
    Scholz, Paula
    MacLaren, Robert E.
    Fauser, Sascha
    Downes, Susan M.
    Hoyng, Carel B.
    Boon, Camiel J. F.
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 259 (04) : 905 - 910
  • [43] Comprehensive evaluation of intravitreal conbercept versus half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Mao, Jian-Bo
    Zhang, Cai-Yun
    Liu, Chen-Yi
    Zhang, Yun
    Lin, Jing-Jing
    Xu, Zhao-Kai
    Chen, Yi-Qi
    Fan, Yuan-Yuan
    Zhao, Shi-Xin
    Shen, Li-Jun
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2021, 14 (05) : 719 - 724
  • [44] Half-dose photodynamic therapy for chronic central serous chorioretinopathy: Efficacy and safety outcomes in real world
    Neves, Filipe
    Costa, Joao
    Fonseca, Sofia
    Silva, Luis
    Agrelos, Luis
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2016, 14 : 173 - 177
  • [45] Comprehensive evaluation of intravitreal conbercept versus half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Jian-Bo Mao
    Cai-Yun Zhang
    Chen-Yi Liu
    Yun Zhang
    Jing-Jing Lin
    Zhao-Kai Xu
    Yi-Qi Chen
    Yuan-Yuan Fan
    Shi-Xin Zhao
    Li-Jun Shen
    International Journal of Ophthalmology, 2021, 14 (05) : 719 - 724
  • [46] Foveal and Extrafoveal Effects of Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy: A Cohort Study
    Pinto, Christophe
    Sousa, Keissy
    Oliveira, Eliana
    Mendonca, Luis
    Gentil, Rita
    Queiros, Lara
    Falcao, Manuel
    SEMINARS IN OPHTHALMOLOGY, 2022, 37 (02) : 153 - 157
  • [47] Long term outer retinal changes in central serous chorioretinopathy submitted to half-dose photodynamic therapy
    Torres-Costa, Sonia
    Penas, Susana
    Cerqueira, Ana Rita
    Brandao, Elisete
    Carneiro, Angela
    Rocha-Sousa, Amandio
    Falcao-Reis, Fernando
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2021, 34
  • [48] Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy
    Thomas J. van Rijssen
    Elon H. C. van Dijk
    Paula Scholz
    Robert E. MacLaren
    Sascha Fauser
    Susan M. Downes
    Carel B. Hoyng
    Camiel J. F. Boon
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2021, 259 : 905 - 910
  • [49] Angiographic and Tomographic Prognostic Factors of Chronic Central Serous Chorioretinopathy Treated with Half-Dose Photodynamic Therapy
    Chung, Chung Yee
    Chan, Yee Yan
    Li, Kenneth K. W.
    OPHTHALMOLOGICA, 2018, 240 (01) : 37 - 44
  • [50] A combination therapy of half-dose verteporfin photodynamic therapy and intravitreal injection of ranibizumab for chronic central serous chorioretinopathy
    Toklu, Yasin
    Cakmak, Hasan Basri
    Yorgun, Mucella Arikan
    Ergun, Sule Berk
    Simsek, Saban
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2012, 42 (04) : 681 - 688